Clinical Trial Update: Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic [Phase 2]

View source ↗

Summary

Phase 2 trial update for perfluorocarbon (ABL-101) oxygenation in acute ischaemic stroke using GOLD imaging theranostic; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischaemic Stroke

Drugs mentioned

• ABL-101 (perfluorocarbon imaging agent)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Acute Ischaemic Stroke | Phase 2 | Status: UNKNOWN